Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators. Cauley JA, et al. Among authors: watts nb. JAMA. 2003 Oct 1;290(13):1729-38. doi: 10.1001/jama.290.13.1729. JAMA. 2003. PMID: 14519707 Clinical Trial.
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC 3rd, Yanover MJ, et al. Watts NB, et al. N Engl J Med. 1990 Jul 12;323(2):73-9. doi: 10.1056/NEJM199007123230201. N Engl J Med. 1990. PMID: 2113611 Free article. Clinical Trial.
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. Harris ST, et al. Among authors: watts nb. JAMA. 1999 Oct 13;282(14):1344-52. doi: 10.1001/jama.282.14.1344. JAMA. 1999. PMID: 10527181 Clinical Trial.
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Chesnut CH 3rd, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D. Chesnut CH 3rd, et al. Am J Med. 2000 Sep;109(4):267-76. doi: 10.1016/s0002-9343(00)00490-3. Am J Med. 2000. PMID: 10996576 Clinical Trial.
Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, Watts NB, Robbins JA, Lewis CE, Beresford SA, Ko MG, Naughton MJ, Satterfield S, Bassford T; Women's Health Initiative Investigators. Jackson RD, et al. Among authors: watts nb. J Bone Miner Res. 2006 Jun;21(6):817-28. doi: 10.1359/jbmr.060312. J Bone Miner Res. 2006. PMID: 16753012 Free article. Clinical Trial.
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N. Kanis JA, et al. Among authors: watts nb. Osteoporos Int. 2007 Aug;18(8):1033-46. doi: 10.1007/s00198-007-0343-y. Epub 2007 Feb 24. Osteoporos Int. 2007. PMID: 17323110 Review.
271 results